Wales National Health Service to be First in UK to Distribute Cannabis Medicine

The National Health Service (NHS) in Wales has announced that it will be the first in the UK to distribute a cannabis-based medicine for the treatment of multiple sclerosis (MS).sativex

According to the NHS, Sativex, a cannabis-based medicine made of one part THC (tetrahydrocannabinol) and one part CBD (cannabidiol), will be available by prescription for those suffering from multiple sclerosis, an autoimmune disease that effects the brain and spinal cord. Sativex is currently approved for use in 24 countries including France, Canada and Switzerland.

Read moreWales National Health Service to be First in UK to Distribute Cannabis Medicine